TRANS LUX Corp
TNLXConsumer Discretionary · Miscellaneous Manufacturing Industries · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $12.9M | $15.6M | $21.7M | $11.3M | $9.4M | $17.0M |
| Operating income | −$2.8M | −$3.0M | −$389,000 | −$4.2M | −$4.6M | −$451,000 |
| Net income | −$3.5M | −$4.1M | $323,000 | −$5.0M | −$4.8M | −$1.4M |
| Total assets | $7.8M | $8.3M | $9.4M | $8.7M | $7.1M | $12.3M |
| Total liabilities | $25.1M | $22.5M | $19.7M | $19.6M | $14.1M | $14.0M |
| Equity | −$17.3M | −$14.2M | −$10.3M | −$10.9M | −$7.0M | −$1.7M |
| EPS (diluted) | $-0.26 | $-0.30 | $0.02 | $-0.37 | $-0.35 | — |
| Shares out. | 13.5M | 13.4M | 13.4M | 13.4M | 13.4M | 13.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −21.5%
- Net margin
- −27.0%
- Return on equity
- 20.1%
- Return on assets
- −44.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 322.1%
- Debt / equity
- —
- Book value / share
- $-1.28
- Revenue growth (YoY)
- −17.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -38.77distress
- Accruals / assets
- −31.8%clean
- Beneish M-Score
- -4.21normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2022
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2021
- NT 10-Qmissed a reporting deadline ↗Aug 17, 2020
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2019
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2015
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 30, 2025 | 3,222 | 1.6 | +1351.3% |
| May 15, 2025 | 222 | 1.0 | +73.4% |
| Apr 30, 2025 | 128 | 1.0 | +509.5% |
| Apr 15, 2025 | 21 | 1.0 | -99.2% |
| Mar 31, 2025 | 2,601 | 2.0 | +591.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeApr 15, 2026
- Director / officer changeSep 9, 2025
- Director / officer changeNov 5, 2024
- Shareholder voteMay 31, 2023
- Director / officer changeApr 21, 2023
- Entered a material agreement · New financial obligationDec 21, 2020
- Director / officer change · Shareholder voteSep 21, 2020
- Entered a material agreement · Unregistered equity saleJul 2, 2020
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KApr 15, 2026
- 10-KFeb 13, 2026
- 8-KFORM 8-KSep 9, 2025
- NT 10-KApr 1, 2025
- 10-QFORM 10-QNov 14, 2024
- 8-KFORM 8-KNov 5, 2024
- 10-QFORM 10-QAug 14, 2024
- 10-QFORM 10-QMay 15, 2024
- 10-KFORM 10-KApr 1, 2024
- SC 13G/AJan 16, 2024
- 10-QFORM 10-QNov 9, 2023
- 10-QFORM 10-QAug 11, 2023
- 8-KFORM 8-KMay 31, 2023
- 10-QFORM 10-QMay 15, 2023
- DEF 14AMay 3, 2023